Log in or Sign up for Free to view tailored content for your specialty!
Transplantation News
Tertiary lymphoid tissues ‘strongly’ associated with late graft dysfunction
The presence of advanced tertiary lymphoid tissues in protocol biopsies correlated with decline in graft function among kidney transplant recipients, according to data published in the Journal of the American Society of Nephrology.
Transplant societies release joint statement recommending COVID-19 vaccinations
The American Society of Transplant Surgeons, the American Society of Transplantation and the International Society for Heart and Lung Transplantation recommend organ transplant patients be vaccinated against COVID-19.
Log in or Sign up for Free to view tailored content for your specialty!
Early second kidney transplantation benefits patients with failing first allograft
Early second kidney transplantations correlate with patient survival compared with those waitlisted and on dialysis, according to data published in the Clinical Journal of the American Society of Nephrology.
Number of stage 3 AKI kidneys transplanted increased from 2010 to 2020
From 2010 to 2020, the number of stage 3 AKI kidneys transplanted has increased, according to data published in American Journal of Transplantation.
NIH awards Penn Medicine $14 million grant to promote kidney transplantation
Penn Medicine received a 7-year, $14 million grant from the NIH to use chimeric antigen receptor T-cell immunotherapies to match patients in need of kidney transplants, according to a press release.
Donor-derived cell-free DNA indicative of allograft injury, eGFR decline
Donor-derived cell-free DNA was determined to be a leading indicator of allograft injury, eGFR decline, formation of de novo donor-specific antibodies and subclinical rejection, according to published data.
Some kidney transplant patients develop COVID-19 antibodies after third vaccine dose
In a study of kidney transplant patients who showed no immune response to two SARS-CoV-2 vaccines, 39% developed antibodies within 4 weeks of a third dose.
FDA approves Livtencity as first treatment for cytomegalovirus infection after transplant
Takeda Pharmaceuticals Company Limited announced FDA approval of Livtencity as the first treatment for patients 12 years or older who weigh at least 35 kg and have cytomegalovirus infection after transplant that is refractory to treatment.
Potassium, phosphorus levels are not definitive judgements for dialysis adherence
Physicians should avoid judging patient adherence to dialysis based on their potassium or phosphorus levels, according to data recently published in Kidney Medicine.
More women die from kidney failure than men
Women face a greater risk for mortality than men following kidney failure, according to a study published in The BMJ.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read